Código QR

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

Leptomeningeal disease (LMD) represents a devastating complication of advanced breast cancer (ABC), with survival of <5 months with multimodal treatment. The role of endocrine therapy (ET), due to its favorable toxicity profile and first-line indication in luminal ABC, appears promising in the setti...

Descrición completa

Gardado en:
Principais autores: Leonor Fernandes, Leonor Vasconcelos de Matos, Débora Cardoso, Marlene Saraiva, Renata Medeiros-Mirra, Andreia Coelho, Helena Miranda, Ana Martins
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis Group 2020-12-01
Series:CNS Oncology
Assuntos:
breast cancer
endocrine therapy
hormonal therapy
leptomeningeal disease
luminal-like breast cancer
meningeal carcinomatosis
Acceso en liña:https://www.futuremedicine.com/doi/10.2217/cns-2020-0023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares